US5851483A - Hygienic agent for use in hemodialysis - Google Patents

Hygienic agent for use in hemodialysis Download PDF

Info

Publication number
US5851483A
US5851483A US08/389,971 US38997195A US5851483A US 5851483 A US5851483 A US 5851483A US 38997195 A US38997195 A US 38997195A US 5851483 A US5851483 A US 5851483A
Authority
US
United States
Prior art keywords
percent
weight
composition
dialysis
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US08/389,971
Inventor
Remy Nicolle
Eric Jourdan-Laforte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Original Assignee
LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9372146&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US5851483(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude filed Critical LAir Liquide SA pour lEtude et lExploitation des Procedes Georges Claude
Priority to US08/389,971 priority Critical patent/US5851483A/en
Priority to US09/187,758 priority patent/US6162394A/en
Application granted granted Critical
Publication of US5851483A publication Critical patent/US5851483A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds

Definitions

  • the present invention concerns a hygienic agent for use in hemodialysis.
  • the principle of the extra corporeal dialysis is based on the contact of the blood to be purified with a dialysate through a semi-permeable membrane.
  • the blood and dialysate In order to obtain efficient exchanges, the blood and dialysate must be permanently renewed, since the speed of diffusion, or of dialysis, depends on the difference of concentrations between the blood and the dialysate. This is obtained by creating an extra-corporeal circulation.
  • Any dialysis chain comprises a generator, a dialyzer, a dialysate and a water circuit.
  • the generators enable to obtain the dialysate, the circulation of the blood and of the dialysate, and the controls of the parameters of dialysis.
  • the artificial kidney or dialyzer permits the elimination of water and of the waste produced by the body by contacting the blood with a liquid which is the dialysate or a dialysis bath.
  • the blood and the dialysate are separated from one and other only by means of a thin artificial organic membrane, of cellophane, cuprophane, polysulfone, polypropylene, polyamide, polyacetate, copolymer of acrylonitrile . . .
  • This membrane can be prepared in the form of plates, as compartments which are piled over one and other, or in the form of coils, as a single compartment which is spirally wounded about an axis or finally as capillaries consisting of an assembly of very fine hollow fibres.
  • the blood circulates inside the envelope defined by the two sheets of the membrane and the dialysate on the outside.
  • the coiled kidney is actually the less utilized.
  • the plate kidneys are all disposed according to the same diagram corresponding to an assembly of 15 to 20 sheets of membrane mounted as an arrangement of plates in a sandwich type fashion, so as to provide inserted blood compartments and dialysate compartments.
  • the blood circulates from top to bottom between the sheets while the dialysate circulates in opposite direction.
  • the hollow fibre kidney contains very little blood; it offers a very weak resistance to the flow of blood.
  • the dialysing surface is formed in the case of thousands of tiny hollow fibres. The blood passes from top to bottom and the dialysate passes around in the other direction.
  • the dialysate is a mixture of water and electrolytes, and the concentration of the electrolytes in the dialysate is provided so that the composition of the electrolytes in the blood is normal at the end of the operation.
  • water should be very pure and chains of hemodialysis are generally provided with a water treatment consisting of softeners, demineralizers, osmosers, filters and a container for storing water. After the container for storing water there is found a utilisation circuit which feeds the dialysis generators.
  • dialyzers are often materials considered to be for single use. However, certain establishments reuse them under the ceremonies of medical doctors. Now the chain of dialysis can very easily be contaminated and this is the reason why it must absolutely be disinfected on a regular basis.
  • Hot sterilization which would represent the ideal hygienic step is actually not feasible because of the numerous elements of the chain of dialysis which are unstable with respect to heat.
  • the products used for disinfection are generally formaldehyde or sodium hypochlorite.
  • the water circuit can be regularly disinfected with formaldehyde or with sodium hypochlorite.
  • This operation is generally carried out once every six months since it is time consuming and requires that the operation of hemodialysis be stopped.
  • Sodium hypochlorite is used under more or less substantial dilutions depending on use, of the order of 50%, for the disinfection of generators.
  • Formaldehyde is also used under more or less substantial dilutions depending on the intended use.
  • various acids are used to remove tartar, such as acetic, lactic, citric acids . . .
  • Peracetic acid whose disinfecting properties are known, has been proposed at a concentration of a few percentages, from the order of 3.5-4%, for the disinfection of generators of dialysis. Under this concentration, this type of disinfecting agent has various disadvantages, including the fact of being a product which presents risks for the treating staff because of its irritating effect on skin and mucous membranes, as well as its corrosive activity on the dialysis material.
  • this new formulation based on peracetic acid increases the properties of one of its active principles. It consists of an aqueous solution containing 6 to 8 weight % hydrogen peroxide, 0.1 to to 1 weight % peracetic acid and 2 to 10 weight % acetic acid.
  • An aqueous solution containing 6 to 8% hydrogen peroxide, 0.3 to 0.4% peracetic acid and 3.5 to 4.5% acetic acid is very advantageous, and in particular an aqueous solution containing 7% hydrogen peroxide, 0.35% peracetic acid and 3.5 to 4% acetic acid.
  • aqueous solutions constituting a hygienic agent for use in hemodialysis are in the form of colorless, non-inflammable liquid which can be mixed with water in all proportions, does not foam, can easily be rinsed, can be kept at room temperature in its original wrapping, and has excellent stability for at least one year.
  • This hygienic agent for use in hemodialysis constitutes a harmless product under normal conditions of use, while permitting the disinfection and tartar removal from the hemodialysis material in a single operation, under the best conditions of hygiene and safety for the staff and the patients, in which no irritations nor allergies have been observed.
  • the new hygienic agent for use in hemodialysis has been shown to be an efficient bactericidal, fungicidal, sporicidal and virucidal agent. Because it is oxidizing and acidic, the hygienic agent for use in hemodialysis frees a particularly active oxygen. It reacts with the proteins of the membrane of the microorganisms and penetrates inside cells to destroy them. Its acidic character provides tartar removal properties.
  • the bactericidal activity of the hygienic agent for use in hemodialysis has been tested on hemodialysis material sequentially contaminated with the following germs: Pseudomonas aerugionsa and Microbacterium smegmatis.
  • Pseudomonas aerugionsa and Microbacterium smegmatis.
  • 10 6 to 10 10 bacteries/ml could be destroyed in 10 to 30 minutes.
  • the hygienic agent for use in hemodialysis was also tested in vitro according to the requirements of the AFNOR norms, and it is important to note that the disinfecting properties were maintained in the presence of organic materials (dialysate, blood, etc . . . ).
  • the fungicidal activity of the hygienic agent has been confirmed in vitro against yeasts and molds.
  • the sporicidic activity was tested in vitro and also on hemodialysis material contaminated with spores of Bacillus cereus. Depending on the apparatuses used, 3 to 10% of a solution of a hygienic agent containing 0.35% peracetic acid destroy 10 4 to 10 6 spores of Bacillus cereus in a period of 10 to 30 minutes.
  • the virucidal activity has been confirmed, such as on the AIDS virus.
  • a contact of 30 minutes with a solution containing 0.35% peracetic acid at a concentration of 1.5% is sufficient to inactivate the HIV (Human Immunodeficiency Virus).
  • the hygienic agent according to the invention is not toxic for patients and staff. On the contrary, it has been observed that allergic and anaphylactic shocks have disappeared as well as a decrease of pyrogenic reactions, often found during dialysis.
  • the lethal dose LD 50 on rat was 1.540 mg/kg for peracetic acid, which corresponds to about 440 g/kg of a solution of hygienic agent containing 0.35% peracetic acid.
  • the toxicity by acute inhalation: LC 50 is about 150 g/m 3 of the solution, the sub-acute toxicity corresponds to 20 g/m 3 and the tolerable threshold for the nose and the eyes is 0.3 g/m 3 .
  • the cutaneous toxicity, with respect to reversible lesions of the occular mucous membrane corresponds to the pure solution, the irritation threshold of the eye corresponds to a solution diluted one tenth.
  • the irritating power on the skin is light with the pure solution and zero with a solution diluted to one tenth.
  • the hygienic agent for use in hemodialysis is biocompatible, and can be metabolized when present in traces. After 10,000 dialyses, no intolerance, irritation or allergy were observed among patients and treating staff. Tests made on blood of healthy donors have established that quantities lower than 0.2% solution of hygienic agent containing 0.35% peracetic acid are harmless and produce no modification of the erythrocytes (counts unchanged), hemoglobin, blood platelets, leukocytes and plasmic proteins. Thus, a concentration which is 150 times higher than the threshold of detection of the tests for rinsing control produced no ill effect on in vitro human blood.
  • the hygienic agent according to the invention finds applications in disinfection and tartar removal in all the stages of the cycle of dialysis.
  • the invention can also be used to make sure that generators awaiting utilisation in a dialysis cycle are kept sterile.
  • the hygienic agent according to the invention enables to disinfect water treatment circuits which are used for hemodialysis, in particular in the recirculation loop.
  • This disinfecting agent can quite easily be used with short contact times, about 30 minutes, which enables to provide weekly or daily treatments according to needs.
  • the agent can be used to disinfect channels, filters, and loops with a decrease of 10 6 to 10 7 germs/ml. Disinfection is followed by rinsing with osmotic water, during a short period of time of the order of 30 minutes to 2 hours depending on the circuits used.
  • the new peracetic acid-hydrogen peroxideacetic acid composition can be used as the single cleaning and disinfection agent in the sterilisation of dialyzers, hemofilters, hemodialyzers.
  • the possibility of reusing dialyzers treated with such composition constitutes a simple method which is very efficient, and well accepted by the treating staff.
  • the composition ensures an average number of 8 to 12 reutilisation times for each dialyzer, under high bacteriological security conditions, thus permitting to consider the possibility of significantly reducing the total cost of the therapeutic treatment while enabling to use "highly permeable" membranes (better quality but very expensive).
  • the germicidal action of the disinfection agent extends for at least 15 days thus permitting an easy preservation of the modules of dialysis from one treatment to the other.
  • the optimal dilution to strip the dialyzers as well as possible seem to be between 1/10th and 2/7th.
  • the average reutilisation number is 8 to 9 with a single automated reconditionning of the modules of dialysis, with an apparatus for reutilisation ensuring a rinsing and cleaning of the high flow blood compartment in the direction of the fibres as well as by retrofiltration.
  • the reutilisation of dialyzers with the recommended dilutions is never associated with a degradation of the filters or of the material to be reutilised.
  • FIG. 1 is a schematic illustration of a chain dialysis used for carrying disinfection according to the invention.
  • Non-limiting examples of application of the hygienic agent according to the invention designated by Dialox® are given hereinafter.
  • the chain of dialysis in which the disinfection tests have been carried out is represented in the annexed figure.
  • This chain comprises generator (1) in which the preparation of the dialysis bath is carried out, from the dialysate sampled in the reservoir (2) and fed toward the generator by means of the circuit (3). Water circulates in the circuit (4) until reaching the generator, and the dilution of the dialysis bath is carried out by means of the measuring pump (5).
  • the dialysis bath leaves the generator via circuit (6) to be introduced in the dialyzer (7), after exchange with the blood of the sick person according to circuit (8a), (8b), and the dialysis bath is sent to a drainage via circuit (9).
  • the generator is placed in position of disinfection, and the tests were carried out with various strains of germs which were purposely introduced in the circuit (3).
  • the generator takes sample on the circuit (3) and automatically dilutes the hygienic agent Dialox® by means of the measuring pump (5).
  • the samples were respectively taken at points (A) on the water circuit (4) before entering the generator, (B) on the circuit (6) of the dialysis bath before entering the dialyzer, (C) on the circuit of the dialysis bath (9) close to the outlet of the dialyzer, and at (D) before rejecting it to be drained.
  • the introduction of the germs is controlled, as well as the samples carried with a series of probes, at the osmotic water inlet (A), inlet of kidney (B), outlet of kidney (C) and drainage outlet (D). In each case, the initial and final count and the decrease of the number of germs are given.
  • Dialox® The germicidal power of the Dialox® has been studied in vitro on used hemodiafilters (HF 80, polysulfone membrane, Fresenius®) which were sequentially contaminated by 3 types of germs (Pseudomonas aeruginosa, Mycobacterium smegmatis and Bacillus cereus in sporulated form).
  • hemodiafilters were submitted to the normal procedure for reutilisation with disinfection by passing through Renatron®, which is an apparatus for reutilisation ensuring a highly efficient rinsing and cleaning of the blood compartment in the direction of the fibres as well as by retrofiltration.
  • the bactericidal power of Dialox® expressed as a logarithmic reduction of the number of germs by ml obtained for the three categories of germs tested as a function of time, is represented in the following table.
  • the reduction on the blood sector as well as on the dialysate sector is between 6 to 7 log after 5 minutes, of contact for a solution of Dialox® diluted 1/10th.
  • the reduction is identical for germs which are sporulated or unsporulated.
  • the bactericidal effect thus appears to be absolute for Dialox® diluted 1/10th after 5 minutes of contact.
  • HF 80 polysulfone membrane Fresenius®
  • Filtral 16 polyacrylonitrile AN69 HOSPAL®
  • FH 88 polyamide membrane, GAMBRO®
  • the reconditionning of the modules of dialysis was carried out automatically on a Renatron® as the treatment was terminated.
  • the cleaning agent was Dialox® at 0.35% peracetic acid.
  • 2/7th, 1/7th, ,1/10th, 1/20th dilutions were used.
  • the dilution used for maintaining the filters sterile from one treatment to the other was 1/10th.
  • Table II indicates the average number of reutilization of 60 modules with 10 patients (represented by their initials) under 2 dilutions of Dialox® at 0.35% peracetic acid, respectively 1/20th and 2/7th.
  • the average number of reutilisation was therefore of 8 (at most 4 to 11 times) with a good possibility of reproduction on the same patient whatever the dilution of Dialox® used.
  • Table IV there is represented the average number of reutilisation of the modules of dialysis depending on their mode of utilisation in hemodialysis (HD), in hemofiltration (FH) or in hemodiafiltration (HDF) under 4 different dilutions of Dialox® at 0.35% peracetic acid, respectively 1/20th, 1/10th, 1/7th and 2/7th.
  • HD hemodialysis
  • FH hemofiltration
  • HDF hemodiafiltration
  • Dialox® 0.35% peracetic acid The influence of the type of dialyzer was studied for the dialysis modules FH 88, HF 80 and FILTRAL 16 at 4 different dilutions of Dialox® 0.35% peracetic acid, respectively 1/20th, 1/10th, 1/7th and 2/7th.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pest Control & Pesticides (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Inorganic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention concerns a hygienic agent for use in hemodialysis. This hygienic agent based on peracetic acid has an aqueous solution containing 6 to 8 weight % hydrogen peroxide, 0.1 to 1 weight % peracetic acid and 2 to 10 weight % acetic acid. Application to the disinfection, sterilization of dialysis generators, dialyzers, hemofilters and hemodialyzers and circuits of water treatment for hemodialysis.

Description

This application is a continuation of parent application Ser. No. 08/111,966 filed Aug. 26, 1993, now abandoned, which is a continuation of Ser. No. 07/653,972 filed Feb. 11, 1991, now abandoned, which is a continuation of Ser. No. 07/438,293 filed Nov. 20, 1989, now abandoned.
BACKGROUND OF INVENTION
(1) Field of the Invention
The present invention concerns a hygienic agent for use in hemodialysis.
(2) Description of Prior Art
The principle of the extra corporeal dialysis is based on the contact of the blood to be purified with a dialysate through a semi-permeable membrane. In order to obtain efficient exchanges, the blood and dialysate must be permanently renewed, since the speed of diffusion, or of dialysis, depends on the difference of concentrations between the blood and the dialysate. This is obtained by creating an extra-corporeal circulation.
Any dialysis chain comprises a generator, a dialyzer, a dialysate and a water circuit.
The generators enable to obtain the dialysate, the circulation of the blood and of the dialysate, and the controls of the parameters of dialysis.
The artificial kidney or dialyzer permits the elimination of water and of the waste produced by the body by contacting the blood with a liquid which is the dialysate or a dialysis bath. The blood and the dialysate are separated from one and other only by means of a thin artificial organic membrane, of cellophane, cuprophane, polysulfone, polypropylene, polyamide, polyacetate, copolymer of acrylonitrile . . . This membrane can be prepared in the form of plates, as compartments which are piled over one and other, or in the form of coils, as a single compartment which is spirally wounded about an axis or finally as capillaries consisting of an assembly of very fine hollow fibres.
Thus, there are three types of dialysis which are often delivered sterile for single use.
In the coiled kidneys, of the type where two sheets of dialysing membrane are spirally wound in a parallel fashion about an axis, the blood circulates inside the envelope defined by the two sheets of the membrane and the dialysate on the outside. The coiled kidney is actually the less utilized.
The plate kidneys are all disposed according to the same diagram corresponding to an assembly of 15 to 20 sheets of membrane mounted as an arrangement of plates in a sandwich type fashion, so as to provide inserted blood compartments and dialysate compartments. The blood circulates from top to bottom between the sheets while the dialysate circulates in opposite direction.
The hollow fibre kidney contains very little blood; it offers a very weak resistance to the flow of blood. Instead of sheets of membrane in roller or plate arrangement, the dialysing surface is formed in the case of thousands of tiny hollow fibres. The blood passes from top to bottom and the dialysate passes around in the other direction.
The dialysate is a mixture of water and electrolytes, and the concentration of the electrolytes in the dialysate is provided so that the composition of the electrolytes in the blood is normal at the end of the operation.
For hemodialysis uses, water should be very pure and chains of hemodialysis are generally provided with a water treatment consisting of softeners, demineralizers, osmosers, filters and a container for storing water. After the container for storing water there is found a utilisation circuit which feeds the dialysis generators.
Since the appearance of the extra-corporeal blood purifying techniques, there were always problems associated with the disinfection and tartar removal from the material used.
The dialyzers are often materials considered to be for single use. However, certain establishments reuse them under the responsability of medical doctors. Now the chain of dialysis can very easily be contaminated and this is the reason why it must absolutely be disinfected on a regular basis.
Clinical reports indicate that important microbial proliferations in hemodialysis apparatuses can have serious effects on patients who are dialysed. More particularly, such phenomenons as bacteremia, hepatitis, fever, shivers, hypotension and shock have been observed.
Hot sterilization which would represent the ideal hygienic step is actually not feasible because of the numerous elements of the chain of dialysis which are unstable with respect to heat.
The addition of impervious filters placed immediately before the dialyzer is not completely satisfactory, since virus, mycoplasma and certain bacteria can pass through these filters.
In addition these physical methods of disinfection require a regular chemical disinfection of the other elements of the chain of dialysis.
In view of all the requirements that an appropriate disinfecting agent should meet, namely a large spectrum of activity for an active time which is as short as possible, cleaning and material preserving properties as well as a capacity to be easily rinsed under controlled conditions, only certain compounds can be considered.
The products used for disinfection are generally formaldehyde or sodium hypochlorite.
The water circuit can be regularly disinfected with formaldehyde or with sodium hypochlorite.
This operation is generally carried out once every six months since it is time consuming and requires that the operation of hemodialysis be stopped.
Sodium hypochlorite is used under more or less substantial dilutions depending on use, of the order of 50%, for the disinfection of generators.
Formaldehyde is also used under more or less substantial dilutions depending on the intended use.
These disinfecting products require multiple manipulations, such as preparations and dilutions . . . and involved risks. Thus, formaldehyde can produce an allergy which is well classified as a professional disease. Sodium hypochlorite brings in chlorine in a highly pure medium, which represents an inconvenience.
Independently in the disinfection, various acids are used to remove tartar, such as acetic, lactic, citric acids . . .
Peracetic acid, whose disinfecting properties are known, has been proposed at a concentration of a few percentages, from the order of 3.5-4%, for the disinfection of generators of dialysis. Under this concentration, this type of disinfecting agent has various disadvantages, including the fact of being a product which presents risks for the treating staff because of its irritating effect on skin and mucous membranes, as well as its corrosive activity on the dialysis material.
Therefore, a search has been made for a new concept of hygienic agent for use in hemodialysis which would meet the following conditions: nontoxicity and biocompatibility in trace amounts, combined disinfection and tartar removal, active time lower than 30 minutes, complete disinfecting effect, easily rinsable and detectable, biodegradable, stable and ready to be used.
SUMMARY OF INVENTION
A hygienic agent for use in hemodialysis fulfilling all the above conditions has been found. In addition, this new formulation based on peracetic acid increases the properties of one of its active principles. It consists of an aqueous solution containing 6 to 8 weight % hydrogen peroxide, 0.1 to to 1 weight % peracetic acid and 2 to 10 weight % acetic acid.
An aqueous solution containing 6 to 8% hydrogen peroxide, 0.3 to 0.4% peracetic acid and 3.5 to 4.5% acetic acid is very advantageous, and in particular an aqueous solution containing 7% hydrogen peroxide, 0.35% peracetic acid and 3.5 to 4% acetic acid.
These aqueous solutions constituting a hygienic agent for use in hemodialysis are in the form of colorless, non-inflammable liquid which can be mixed with water in all proportions, does not foam, can easily be rinsed, can be kept at room temperature in its original wrapping, and has excellent stability for at least one year.
This hygienic agent for use in hemodialysis constitutes a harmless product under normal conditions of use, while permitting the disinfection and tartar removal from the hemodialysis material in a single operation, under the best conditions of hygiene and safety for the staff and the patients, in which no irritations nor allergies have been observed.
With a complete spectrum disinfecting formula, the new hygienic agent for use in hemodialysis has been shown to be an efficient bactericidal, fungicidal, sporicidal and virucidal agent. Because it is oxidizing and acidic, the hygienic agent for use in hemodialysis frees a particularly active oxygen. It reacts with the proteins of the membrane of the microorganisms and penetrates inside cells to destroy them. Its acidic character provides tartar removal properties.
The bactericidal activity of the hygienic agent for use in hemodialysis has been tested on hemodialysis material sequentially contaminated with the following germs: Pseudomonas aerugionsa and Microbacterium smegmatis. Depending on the dilutions used for the apparatuses, which consist of 3 to 10% aqueous solution containing 7% H2 O2, 0.35% peracetic acid and 3.5% acetic acid, 106 to 1010 bacteries/ml could be destroyed in 10 to 30 minutes.
The hygienic agent for use in hemodialysis was also tested in vitro according to the requirements of the AFNOR norms, and it is important to note that the disinfecting properties were maintained in the presence of organic materials (dialysate, blood, etc . . . ).
The fungicidal activity of the hygienic agent has been confirmed in vitro against yeasts and molds.
The sporicidic activity was tested in vitro and also on hemodialysis material contaminated with spores of Bacillus cereus. Depending on the apparatuses used, 3 to 10% of a solution of a hygienic agent containing 0.35% peracetic acid destroy 104 to 106 spores of Bacillus cereus in a period of 10 to 30 minutes.
The virucidal activity has been confirmed, such as on the AIDS virus. A contact of 30 minutes with a solution containing 0.35% peracetic acid at a concentration of 1.5% is sufficient to inactivate the HIV (Human Immunodeficiency Virus).
The hygienic agent according to the invention is not toxic for patients and staff. On the contrary, it has been observed that allergic and anaphylactic shocks have disappeared as well as a decrease of pyrogenic reactions, often found during dialysis.
The lethal dose LD 50 on rat was 1.540 mg/kg for peracetic acid, which corresponds to about 440 g/kg of a solution of hygienic agent containing 0.35% peracetic acid. The toxicity by acute inhalation: LC 50 is about 150 g/m3 of the solution, the sub-acute toxicity corresponds to 20 g/m3 and the tolerable threshold for the nose and the eyes is 0.3 g/m3. The cutaneous toxicity, with respect to reversible lesions of the occular mucous membrane corresponds to the pure solution, the irritation threshold of the eye corresponds to a solution diluted one tenth. The irritating power on the skin is light with the pure solution and zero with a solution diluted to one tenth.
The hygienic agent for use in hemodialysis is biocompatible, and can be metabolized when present in traces. After 10,000 dialyses, no intolerance, irritation or allergy were observed among patients and treating staff. Tests made on blood of healthy donors have established that quantities lower than 0.2% solution of hygienic agent containing 0.35% peracetic acid are harmless and produce no modification of the erythrocytes (counts unchanged), hemoglobin, blood platelets, leukocytes and plasmic proteins. Thus, a concentration which is 150 times higher than the threshold of detection of the tests for rinsing control produced no ill effect on in vitro human blood.
The hygienic agent according to the invention finds applications in disinfection and tartar removal in all the stages of the cycle of dialysis.
It enables to disinfect and remove tartar from dialysis generators within less than one hour, including rinsing time. It can be used for a rapid disinfection between two dialysis treatments. Tartar removal from generators is realised simultaneously as their disinfection and there is no need to use another acid. Disinfection is carried out while the chemical disinfection cycle of the generators take place, and the periods of contact and rinsing are adjusted on the apparatuses, generally between 20 to 30 minutes of contact and 30 minutes of rinsing with osmotic water. For a normal chemical disinfection cycle it is recommended to use a dilution between 1/10th and 1/35th, preferably 1/30th.
The invention can also be used to make sure that generators awaiting utilisation in a dialysis cycle are kept sterile.
The hygienic agent according to the invention enables to disinfect water treatment circuits which are used for hemodialysis, in particular in the recirculation loop. This disinfecting agent can quite easily be used with short contact times, about 30 minutes, which enables to provide weekly or daily treatments according to needs. The agent can be used to disinfect channels, filters, and loops with a decrease of 106 to 107 germs/ml. Disinfection is followed by rinsing with osmotic water, during a short period of time of the order of 30 minutes to 2 hours depending on the circuits used.
The new peracetic acid-hydrogen peroxideacetic acid composition can be used as the single cleaning and disinfection agent in the sterilisation of dialyzers, hemofilters, hemodialyzers. The possibility of reusing dialyzers treated with such composition constitutes a simple method which is very efficient, and well accepted by the treating staff. The composition ensures an average number of 8 to 12 reutilisation times for each dialyzer, under high bacteriological security conditions, thus permitting to consider the possibility of significantly reducing the total cost of the therapeutic treatment while enabling to use "highly permeable" membranes (better quality but very expensive).
The germicidal action of the disinfection agent extends for at least 15 days thus permitting an easy preservation of the modules of dialysis from one treatment to the other.
Under conditions of automated reutilisation, the optimal dilution to strip the dialyzers as well as possible seem to be between 1/10th and 2/7th. In this case, the average reutilisation number is 8 to 9 with a single automated reconditionning of the modules of dialysis, with an apparatus for reutilisation ensuring a rinsing and cleaning of the high flow blood compartment in the direction of the fibres as well as by retrofiltration. The reutilisation of dialyzers with the recommended dilutions is never associated with a degradation of the filters or of the material to be reutilised.
BRIEF DESCRIPTION OF DRAWINGS
FIG. 1 is a schematic illustration of a chain dialysis used for carrying disinfection according to the invention.
DESCRIPTION OF PREFERRED EMBODIMENTS
Non-limiting examples of application of the hygienic agent according to the invention designated by Dialox® are given hereinafter.
EXAMPLE 1 Disinfection of generators of dialysis
The chain of dialysis in which the disinfection tests have been carried out, is represented in the annexed figure.. This chain comprises generator (1) in which the preparation of the dialysis bath is carried out, from the dialysate sampled in the reservoir (2) and fed toward the generator by means of the circuit (3). Water circulates in the circuit (4) until reaching the generator, and the dilution of the dialysis bath is carried out by means of the measuring pump (5). The dialysis bath leaves the generator via circuit (6) to be introduced in the dialyzer (7), after exchange with the blood of the sick person according to circuit (8a), (8b), and the dialysis bath is sent to a drainage via circuit (9).
For this series of tests the generator is placed in position of disinfection, and the tests were carried out with various strains of germs which were purposely introduced in the circuit (3). The generator takes sample on the circuit (3) and automatically dilutes the hygienic agent Dialox® by means of the measuring pump (5).
These tests were carried out in various types of generators with different dilutions of Dialox® corresponding to a solution containing 0.35% peracetic acid, 7% H2 O2 and 3.5% acetic acid and contact times between 10 to 30 minutes.
The samples were respectively taken at points (A) on the water circuit (4) before entering the generator, (B) on the circuit (6) of the dialysis bath before entering the dialyzer, (C) on the circuit of the dialysis bath (9) close to the outlet of the dialyzer, and at (D) before rejecting it to be drained.
The introduction of the germs is controlled, as well as the samples carried with a series of probes, at the osmotic water inlet (A), inlet of kidney (B), outlet of kidney (C) and drainage outlet (D). In each case, the initial and final count and the decrease of the number of germs are given.
EXAMPLE 1a
Generator of the type Frenesius®.
              TABLE Ia                                                    
______________________________________                                    
Site of  Initial count/                                                   
                      Final count/                                        
                                Decrease                                  
sampling ml           50 ml     log 10                                    
______________________________________                                    
Strain                Pseudomonas aeruginosa                              
Dilution              DIALOX ® 1/35th                                 
Time (T.) of contact  20 min. (mn)                                        
A        0            0          0.00                                     
B        8.00E + 08   0         10.60                                     
C        8.00E + 08   0         10.60                                     
D        8.00E + 08   0         10.60                                     
Strain                Spores of Bacillus cereus                           
Dilution              DIALOX ® 1/35th                                 
T. of contact         20 mn                                               
A        0            0         0.00                                      
B        3.00E + 06   0         8.18                                      
C        3.00E + 06   0         8.18                                      
D        6.00E + 06   0         8.48                                      
______________________________________
EXAMPLE 1b
Generator of the type Monitral
              TABLE IB                                                    
______________________________________                                    
Site of  Initial count/                                                   
                      Final count/                                        
                                Decrease                                  
sampling ml           50 ml     log 10                                    
______________________________________                                    
Strain                Pseudomonas aeruginosa                              
Dilution              DIALOX`® 1/35th                                 
T. of contact         30 mn                                               
A        0            0         0.00                                      
B        1.00E + 06   0         7.70                                      
C        1.00E + 06   0         7.70                                      
D        1.00E + 07   0         8.70                                      
Strain                Mycobacterium smegmatis                             
Dilution              DIALOX ® 1/35th                                 
T. of contact         30 mn                                               
A        0            0         0.00                                      
B        1.00E + 06   0         7.70                                      
C        1.00E + 06   0         7.70                                      
D        1.00E + 06   0         8.70                                      
Strain                Spores of Bacillus cereus                           
Dilution              DIALOX ® 1/35th                                 
T. of contact         30 mn                                               
A        0            0         0.00                                      
B        4.00E + 06   0         8.30                                      
C        4.00E + 06   0         8.30                                      
D        7.00E + 06   0         8.54                                      
______________________________________
EXAMPLE 1c
Generator of the type AK 10
              TABLE IC                                                    
______________________________________                                    
Strain        Pseudomonas aeruginosa                                      
Dilution      DIALOX ® 1/35th                                         
T. of contact 20 mn                                                       
Site of   Initial count/                                                  
                       Final count/                                       
                                 Decrease                                 
sampling  ml           50 ml     log 10                                   
______________________________________                                    
A         0            0         0.00                                     
B         6.00E+08     0         10.48                                    
C         6.00E+08     0         10.48                                    
D         6.00E+08     0         10.48                                    
______________________________________                                    
Strain        Mycobacterium smegmatis                                     
Dilution      DIALOX ® 1/35th                                         
T. of contact 10 mn                                                       
Site of   Initial count/                                                  
                       Final count/                                       
                                 Decrease                                 
sampling  ml           50 ml     log 10                                   
______________________________________                                    
A         0            0         0.00                                     
B         1.00E+07     0         8.70                                     
C         1.00E+07     0         8.70                                     
D         9.00E+07     0         9.65                                     
______________________________________                                    
Strain        Spores of Bacillus cereus                                   
Dilution      DIALOX ® 1/35th                                         
T. of contact 10 mn                                                       
Site of   Initial count/                                                  
                       Final count/                                       
                                 Decrease                                 
sampling  ml           50 ml     log 10                                   
______________________________________                                    
A         0            0         0.00                                     
B         1.00E+06     900       4.74                                     
C         1.00E+06     700       4.85                                     
D         2.00E+06     1000      5.00                                     
______________________________________                                    
Strain        Spores of Bacillus cereus                                   
Dilution      DIALOX ® 1/35th                                         
T. of contact 10 mn                                                       
Site of   Initial count/                                                  
                       Final count/                                       
                                 Decrease                                 
sampling  ml           50 ml     log 10                                   
______________________________________                                    
A         0            0         0.00                                     
B         8.00E+06     5000      4.90                                     
C         8.00E+06     4000      5.00                                     
D         1.00E+07     3000      5.22                                     
______________________________________                                    
Strain        Spores of Bacillus cereus                                   
Dilution      DIALOX ® 1/35th                                         
T. of contact 10 mn                                                       
Site of   Initial count/                                                  
                       Final count/                                       
                                 Decrease                                 
sampling  ml           50 ml     log 10                                   
______________________________________                                    
A         0            0         0.00                                     
B         4.00E+06     0         8.30                                     
C         4.00E+06     0         8.30                                     
D         4.00E+06     0         8.30                                     
______________________________________
EXAMPLE 1d
Comparative test for the disinfection of a generator of the type AK 10 (GAMBRO)®
              TABLE Id                                                    
______________________________________                                    
Strain        Spores of Bacillus cereus                                   
Dilution      4% formaldehyde                                             
T. of contact 12 hours                                                    
Site of   Initial count/                                                  
                       Final count/                                       
                                 Decrease                                 
sampling  ml           50 ml     log 10                                   
______________________________________                                    
A         0            0         0.00                                     
B         1.00E+06     300       5.22                                     
C         1.00E+06     500       5.00                                     
D         1.00E+06     150       5.52                                     
______________________________________
EXAMPLE 2
Ex vivo study of the germicidal power of an aqueous solution containing 3.5% peracetic acid, 7% H2 O2 and 3.5% acetic acid (Dialox®).
The germicidal power of the Dialox® has been studied in vitro on used hemodiafilters (HF 80, polysulfone membrane, Fresenius®) which were sequentially contaminated by 3 types of germs (Pseudomonas aeruginosa, Mycobacterium smegmatis and Bacillus cereus in sporulated form).
For each type of germ 5 hemodiafilters were used: the first was used as indicator of contamination and the four others were used as indicator of the efficiency of the disinfecting product. These hemodiafilters were submitted to the normal procedure for reutilisation with disinfection by passing through Renatron®, which is an apparatus for reutilisation ensuring a highly efficient rinsing and cleaning of the blood compartment in the direction of the fibres as well as by retrofiltration.
These times of contact of the membranes with the disinfecting solution were respectively 5, 10, 20 and 30 minutes, and the count of the colonies of germs collected on the membranes were carried out at the 24th, 48th, 72nd and 96th hour of culture period.
The bactericidal power of Dialox® expressed as a logarithmic reduction of the number of germs by ml obtained for the three categories of germs tested as a function of time, is represented in the following table.
              TABLE II                                                    
______________________________________                                    
                      Count                                               
Time    Count         after contact                                       
                                Reduction                                 
Minutes A T = 0       time      LOG 10                                    
______________________________________                                    
PSEUDOMONAS AEROGINOSA                                                    
5       1.2 · 10.sup.7 g/ml                                      
                      0         7.08                                      
10      1.2 · 10.sup.7 g/ml                                      
                      0         7.08                                      
15      1.2 · 10.sup.7 g/ml                                      
                      0         7.08                                      
20      1.2 · 10.sup.7 g/ml                                      
                      0         7.08                                      
MYCOBACTERIUM SMEGMATIS                                                   
5       5.1 · 10.sup.7 g/ml                                      
                      0         7.71                                      
10      5.1 · 10.sup.7 g/ml                                      
                      0         7.71                                      
15      5.1 · 10.sup.7 g/ml                                      
                      0         7.71                                      
20      5.1 · 10.sup.7 g/ml                                      
                      0         7.71                                      
BACILLUS CEREUS SPORULE                                                   
5       4.0 · 10.sup.7 g/ml                                      
                      0         6.60                                      
10      4.0 · 10.sup.7 g/ml                                      
                      0         6.60                                      
15      4.0 · 10.sup.7 g/ml                                      
                      0         6.60                                      
20      4.0 · 10.sup.7 g/ml                                      
                      0         6.60                                      
______________________________________
For a contaminating solution comprising 106 to 107 units forming colonies (U.F.C.)/ml, the reduction on the blood sector as well as on the dialysate sector is between 6 to 7 log after 5 minutes, of contact for a solution of Dialox® diluted 1/10th. The reduction is identical for germs which are sporulated or unsporulated. The bactericidal effect thus appears to be absolute for Dialox® diluted 1/10th after 5 minutes of contact.
EXAMPLE 3
In vivo study of the cleaning and disinfecting effect of Dialox® on the modules of dialysis.
This in vivo evaluation was carried out on ten patients in stable condition of chronic kidney insufficiency, for extra kidney assistance, by hemodialysis, hemofiltration or hemodiafiltration.
Three models of dialyzers were used: HF 80 (polysulfone membrane Fresenius®), Filtral 16 polyacrylonitrile AN69 HOSPAL®, FH 88 (polyamide membrane, GAMBRO®). 6 dialyzers have been used for each patient.
The reconditionning of the modules of dialysis was carried out automatically on a Renatron® as the treatment was terminated.
The cleaning agent was Dialox® at 0.35% peracetic acid. For cleaning filters, 2/7th, 1/7th, ,1/10th, 1/20th dilutions were used. The dilution used for maintaining the filters sterile from one treatment to the other was 1/10th.
Table II indicates the average number of reutilization of 60 modules with 10 patients (represented by their initials) under 2 dilutions of Dialox® at 0.35% peracetic acid, respectively 1/20th and 2/7th.
              TABLE III                                                   
______________________________________                                    
Reaction of patient                                                       
______________________________________                                    
Patient   BC        CJ     RY      FA   EK                                
Filter    FH88      FH88   FH88    HF80 HF80                              
______________________________________                                    
Dilution                                                                  
of Dialox ®                                                           
1/20th    7         8.2    5.3     4.3  9.5                               
2/7th     8.5       7.7    6.2     6.0  9.8                               
X                                                                         
______________________________________                                    
Patient   EA        EF     TR      DV   FP                                
Filter    FH80      HF80   HF80    F16  F16                               
______________________________________                                    
Dilution                                                                  
of Dialox ®                                                           
1/20th    9.7       9.8    9.2     7.7  11.2                              
2/7th     10        10.2   9.8     7.8  10.3                              
X                                                                         
______________________________________                                    
 X: number of reutilisation average/patient.
The average number of reutilisation was therefore of 8 (at most 4 to 11 times) with a good possibility of reproduction on the same patient whatever the dilution of Dialox® used.
In Table IV there is represented the average number of reutilisation of the modules of dialysis depending on their mode of utilisation in hemodialysis (HD), in hemofiltration (FH) or in hemodiafiltration (HDF) under 4 different dilutions of Dialox® at 0.35% peracetic acid, respectively 1/20th, 1/10th, 1/7th and 2/7th.
              TABLE IV                                                    
______________________________________                                    
Influence of the method of dialysis                                       
Dilution                                                                  
of Dialox ®                                                           
           HF           HDF    HD                                         
______________________________________                                    
1/20th                                                                    
X          6.2          9.5     9.4                                       
n          (18)         (30)   (12)                                       
1/10th                                                                    
X          7.5          9      10.5                                       
n           (3)          (5)   (2)                                        
1/7th                                                                     
X          7.1          10.0    9.1                                       
n          (18)         (30)   (12)                                       
2/7th                                                                     
X          7.3          9.2    10.0                                       
n           (3)          (5)   (2)                                        
______________________________________                                    
 n: total number of tests.                                                
 X: average number of reutilisation/method.
The influence of the method of dialysis is clear when comparing the 2 most representative groups, namely those corresponding to 1/20th and 1/7th dilutions. These data establish that the modules used in hemofiltration have an average number of reutilisation significantly lower than those used in hemodialysis or in hemodiafiltration.
The influence of the type of dialyzer was studied for the dialysis modules FH 88, HF 80 and FILTRAL 16 at 4 different dilutions of Dialox® 0.35% peracetic acid, respectively 1/20th, 1/10th, 1/7th and 2/7th.
The average number of reutilisation (X) by dialyzer is given in table V.
              TABLE V                                                     
______________________________________                                    
Influence of the type of dialyzer                                         
Dilution                                                                  
of Dialox ®                                                           
           HF88         HF80   F16                                        
______________________________________                                    
1/20th                                                                    
X          5.2          7.1    6.3                                        
n          (30)         (50)   (20)                                       
1/10th                                                                    
X          5.3          7.6    7.1                                        
n           (3)          (5)    (2)                                       
1/7th                                                                     
X          5.7          7.7    6.2                                        
n           (30)        (50)    (20)                                      
2/7th                                                                     
X          5.3          7.8    7.0                                        
n          (3)           (5)   (2)                                        
______________________________________                                    
 n: total number of tests.                                                
 X: average number of reutilization/dialyzer.
These data establish that there is a significant difference only between hemofilters FH88® and the group of hemodiafilters HF80® and FILTRAL 16®.
During this program of reutilisation of the module of dialysis no particular reaction was observed on the patients and the performances of the dialysis were not affected significantly by the reutilisation.
EXAMPLE 4
Disinfection of the water circuit.
In this type of disinfection, there was used a disinfecting agent containing 0.35% peracetic acid, Dialox®, at a dose of 5 liters for 100 liters of water injected in a buffer capacity. During disinfection, the circulation pumps of the circuit should operate to circulate the mixture of water and disinfecting agent. The circulation/disinfection time of contact is 30 minutes. Rinsing of the circuit is not carried out with osmotic water.

Claims (8)

We claim:
1. A method of disinfecting and removing tartar from interior portions of a dialysis generator, the method comprising the steps of:
introducing into the dialysis generator a sterilization composition consisting essentially of an aqueous solution of 6 to 8 percent by weight hydrogen peroxide, 0.3 to 0.4 percent by weight peracetic acid, and 3.5 to 4.5 percent by weight acetic acid, the composition remaining stable for at least a year;
adjusting the dialysis generator so that the sterilization composition is automatically diluted in water by the ratio of composition-to-water of 1:10 to 1:35 to provide a diluted cleaning composition and so that the diluted composition is placed in contact with the interior portions of the dialysis generator for a period of 20 to 30 minutes; and
rinsing the contacted interior portions of the dialysis generator with osmotic water for a period of about 30 minutes.
2. The method of claim 1, wherein the sterilization composition consists essentially of an aqueous solution of 7 percent by weight hydrogen peroxide, 0.35 percent by weight peracetic acid, and 3.5 to 4 percent by weight acetic acid.
3. A method of disinfecting and removing tartar from water treatment circuits of dialysis equipment, the method comprising the steps of:
diluting a sterilization composition which remains stable for at least a year and which consists essentially of an aqueous solution of 6 to 8 percent by weight hydrogen peroxide, 0.3 to 0.4 percent by weight peracetic acid, and 3.5 to 4.5 percent by weight acetic acid in water by the ratio of composition-to-water of 1:10 to 1:35 to provide a diluted composition;
placing the diluted composition in contact with the water treatment circuits of the dialysis equipment for a period of about 30 minutes; and
rinsing the contacted water treatment circuits with osmotic water for a period of 30 minutes to 2 hours.
4. The method of claim 3, wherein the sterilization composition consists essentially of an aqueous solution of 7 percent by weight hydrogen peroxide, 0.35 percent by weight peracetic acid, and 3.5 to 4 percent by weight acetic acid.
5. A method of disinfecting and removing tartar from interior portions of dialyzers, hemofilters and hemodialyzers, the method comprising the steps of:
diluting a sterilization composition, which remains stable for at least a year and which consists essentially of an aqueous solution of 6 to 8 percent by weight hydrogen peroxide, 0.3 to 0.4 percent by weight peracetic acid, and 3.5 to 4.5 percent by weight acetic acid in water by the ratio of composition-to-water of 1:10 to 2:7 to provide a diluted composition;
placing the diluted composition in contact with the interior portions of the dialyzers, hemofilters and hemodialyzers for a period of 20 to 30 minutes; and
rinsing the contacted interior portions of the dialysis generator with osmotic water for a period of about 30 minutes.
6. The method of claim 5, wherein the sterilization composition consists essentially of an aqueous solution of 7 percent by weight hydrogen peroxide, 0.35 percent by weight peracetic acid, and 3.5 to 4 percent by weight acetic acid.
7. A composition for disinfecting and removing tartar from dialysis equipment, consisting essentially of an aqueous solution of 6 to 8 percent by weight hydrogen peroxide, 0.3 to 0.4 percent peracetic acid, and 3.5 to 4.5 percent by weight acetic acid.
8. The composition according to claim 7, consisting essentially of an aqueous solution of about 7 percent by weight hydrogen peroxide, about 0.35 percent peracetic acid, and 3.5 to 4 percent by weight acetic acid.
US08/389,971 1988-11-23 1995-02-16 Hygienic agent for use in hemodialysis Expired - Fee Related US5851483A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US08/389,971 US5851483A (en) 1988-11-23 1995-02-16 Hygienic agent for use in hemodialysis
US09/187,758 US6162394A (en) 1988-11-23 1998-11-09 Hygienic agent for use in hemodialysis

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR8815252A FR2639233B1 (en) 1988-11-23 1988-11-23 HEMODIALYSIS HYGIENE AGENT
FR8815252 1988-11-23
US43829389A 1989-11-20 1989-11-20
US65397291A 1991-02-11 1991-02-11
US11196693A 1993-08-26 1993-08-26
US08/389,971 US5851483A (en) 1988-11-23 1995-02-16 Hygienic agent for use in hemodialysis

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
US43829389A Continuation 1988-11-23 1989-11-20
US65397291A Continuation 1988-11-23 1991-02-11
US11196693A Continuation 1988-11-23 1993-08-26

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/187,758 Division US6162394A (en) 1988-11-23 1998-11-09 Hygienic agent for use in hemodialysis

Publications (1)

Publication Number Publication Date
US5851483A true US5851483A (en) 1998-12-22

Family

ID=9372146

Family Applications (2)

Application Number Title Priority Date Filing Date
US08/389,971 Expired - Fee Related US5851483A (en) 1988-11-23 1995-02-16 Hygienic agent for use in hemodialysis
US09/187,758 Expired - Fee Related US6162394A (en) 1988-11-23 1998-11-09 Hygienic agent for use in hemodialysis

Family Applications After (1)

Application Number Title Priority Date Filing Date
US09/187,758 Expired - Fee Related US6162394A (en) 1988-11-23 1998-11-09 Hygienic agent for use in hemodialysis

Country Status (8)

Country Link
US (2) US5851483A (en)
EP (1) EP0370850B1 (en)
JP (1) JP2599204B2 (en)
AT (1) ATE92254T1 (en)
CA (1) CA2003476C (en)
DE (1) DE68908101T2 (en)
ES (1) ES2043067T3 (en)
FR (1) FR2639233B1 (en)

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162394A (en) * 1988-11-23 2000-12-19 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Hygienic agent for use in hemodialysis
US6168808B1 (en) * 1997-04-24 2001-01-02 Chemoxal Sa Synergistic composition of peracetic acid and amine oxide
WO2001019414A1 (en) * 1999-09-16 2001-03-22 Metrex Research Corporation Cleaning and decontaminating dialyzers by per-compound solutions
WO2001036076A1 (en) * 1999-11-12 2001-05-25 Minntech Corporation Method and product for cleaning hollow fiber material and filter
US6479454B1 (en) 2000-10-05 2002-11-12 Ecolab Inc. Antimicrobial compositions and methods containing hydrogen peroxide and octyl amine oxide
US6545047B2 (en) 1998-08-20 2003-04-08 Ecolab Inc. Treatment of animal carcasses
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US6627593B2 (en) 2001-07-13 2003-09-30 Ecolab Inc. High concentration monoester peroxy dicarboxylic acid compositions, use solutions, and methods employing them
US20040060865A1 (en) * 1998-10-20 2004-04-01 Robin Callan Buffered compositions for dialysis
US20050025667A1 (en) * 2003-06-23 2005-02-03 Novasterilis Inc. Sterilization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
US20050119598A1 (en) * 1999-09-22 2005-06-02 Advanced Renal Technologies High citrate dialysate and uses thereof
US6927237B2 (en) 2000-04-28 2005-08-09 Ecolab Inc. Two solvent antimicrobial compositions and methods employing them
WO2005092397A1 (en) * 2004-03-01 2005-10-06 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Dialyzing plant
US6964787B2 (en) 2001-02-01 2005-11-15 Ecolab Inc. Method and system for reducing microbial burden on a food product
US7060301B2 (en) 2001-07-13 2006-06-13 Ecolab Inc. In situ mono-or diester dicarboxylate compositions
US7150884B1 (en) 2000-07-12 2006-12-19 Ecolab Inc. Composition for inhibition of microbial growth
US7316824B2 (en) 2000-12-15 2008-01-08 Ecolab Inc. Method and composition for washing poultry during processing
US7381439B2 (en) 2000-12-15 2008-06-03 Ecolab Inc. Method and composition for washing poultry during processing
US20080166266A1 (en) * 2003-06-23 2008-07-10 Burns David C Method and Apparatus for Cleaning of Viable Donor Soft Tissue
US7498051B2 (en) 2004-01-09 2009-03-03 Ecolab Inc. Methods for washing poultry during processing with medium chain peroxycarboxylic acid compositions
US7504124B2 (en) 2004-01-09 2009-03-17 Ecolab Inc. Methods for washing carcasses, meat, or meat product with medium chain peroxycarboxylic acid compositions
US7547421B2 (en) 2006-10-18 2009-06-16 Ecolab Inc. Apparatus and method for making a peroxycarboxylic acid
US7569232B2 (en) 2004-01-09 2009-08-04 Ecolab Inc. Medium chain peroxycarboxylic acid compositions
US20090246193A1 (en) * 2003-06-23 2009-10-01 Christensen Tim W Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
US7622606B2 (en) 2003-01-17 2009-11-24 Ecolab Inc. Peroxycarboxylic acid compositions with reduced odor
US20100076082A1 (en) * 2007-04-12 2010-03-25 Bioxal New Cleaning, Descaling and Disinfecting Composition for Dialysis Generators
US7754670B2 (en) 2005-07-06 2010-07-13 Ecolab Inc. Surfactant peroxycarboxylic acid compositions
US7887641B2 (en) 2004-01-09 2011-02-15 Ecolab Usa Inc. Neutral or alkaline medium chain peroxycarboxylic acid compositions and methods employing them
US20110091354A1 (en) * 2009-10-15 2011-04-21 Minntech Corporation Room fogging disinfection system
US20110135537A1 (en) * 2009-12-03 2011-06-09 Minntech Corporation Container and system for decontaminating a medical device with a fog
US8075857B2 (en) 2006-10-18 2011-12-13 Ecolab Usa Inc. Apparatus and method for making a peroxycarboxylic acid
US8974730B2 (en) 2003-06-23 2015-03-10 Novasterilis, Inc. Process for creating acellular viable donor soft tissue
US8999175B2 (en) 2004-01-09 2015-04-07 Ecolab Usa Inc. Methods for washing and processing fruits, vegetables, and other produce with medium chain peroxycarboxylic acid compositions
US9017607B2 (en) 2011-05-27 2015-04-28 Medivators Inc. Decontamination system including environmental control using a decontaminating substance
US20150305342A1 (en) * 2014-04-28 2015-10-29 American Sterilizer Company Process and composition for killing spores
US20150305343A1 (en) * 2014-04-28 2015-10-29 American Sterilizer Company Process and composition for killing spores
US20150306266A1 (en) * 2014-04-28 2015-10-29 American Sterilizer Company Process for decontaminating or sterilizing an article
US20160021888A1 (en) * 2014-04-28 2016-01-28 American Sterilizer Company Wipe for killing spores
US9511161B2 (en) 2004-01-09 2016-12-06 Ecolab Usa Inc. Methods for reducing the population of arthropods with medium chain peroxycarboxylic acid compositions
US9752105B2 (en) 2012-09-13 2017-09-05 Ecolab Usa Inc. Two step method of cleaning, sanitizing, and rinsing a surface
US11241658B2 (en) 2018-02-14 2022-02-08 Ecolab Usa Inc. Compositions and methods for the reduction of biofilm and spores from membranes
US11865219B2 (en) 2013-04-15 2024-01-09 Ecolab Usa Inc. Peroxycarboxylic acid based sanitizing rinse additives for use in ware washing

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3936785C1 (en) * 1989-11-04 1991-03-28 Fresenius Ag, 6380 Bad Homburg, De
US5268144A (en) * 1989-11-04 1993-12-07 Fresenius Ag Method for sterilizing a medical unit
EP0649310B1 (en) * 1991-07-15 2001-02-07 Minntech Corporation Stable, anticorrosive peracetic/peroxide sterilant
NL9200386A (en) * 1992-03-03 1993-10-01 Physio B V DEVICE AND METHOD FOR DISINFECTING A DEVICE FOR BREATHING PATIENTS.
GB9219465D0 (en) * 1992-09-15 1992-10-28 Solvay Interox Ltd Microbicidal compositions and methods
JP3197371B2 (en) * 1992-11-04 2001-08-13 稲畑香料株式会社 Peracetic acid-based germicidal composition having an aroma and bleach composition
FR2704726B1 (en) * 1993-05-05 1995-06-16 Chemoxal Sa Aqueous composition comprising an organic peroxyacid and its uses as disinfecting agents.
FR2728143A1 (en) 1994-12-16 1996-06-21 Sodifra AQUEOUS COMPOSITION BASED ON H2O2, ACIDS AND AG, PROCESS FOR PREPARATION AND USE IN THE FIELD OF DISINFECTION AND / OR HYGIENE
ES2120372B1 (en) * 1996-07-31 1999-06-16 Uniclor Asturias S L NEW DOMESTIC USE OF A LIQUID COMPOSITION GIVEN WITH BLEACHING AND DISINFECTING PROPERTIES.
ES2191211T3 (en) * 1996-12-13 2003-09-01 Chemoxal Sa USE OF PERACETIC ACID IN PISCICULTURE.
FR2792500B1 (en) 1999-04-23 2004-05-21 Internat Redox Dev AQUEOUS COMPOSITION, IN PARTICULAR IN THE FORM OF GEL, BASED ON HO2F, ACIDS AND METAL IONS, PREPARATION METHOD, PARTICULARLY WHEN THE SAID IONS ARE AG2 + AND USE IN THE FIELD OF DISINFECTION AND / OR SURFACE TREATMENT
FR2796283B1 (en) * 1999-07-12 2002-05-10 Seppic Sa AUTOMATIC PROCESS FOR DISINFECTING ENDOSCOPES USING AN AQUEOUS SOLUTION OF PERACETIC ACID AND HYDROGEN PEROXIDE
FR2796284B1 (en) * 1999-07-12 2002-05-24 Seppic Sa MANUAL PROCESS FOR THE DISINFECTION OF MEDICAL AND SURGICAL MATERIALS AND DENTISTRY USING AN AQUEOUS SOLUTION OF PERACETIC ACID AND HYDROGEN PEROXIDE
FR2797592B1 (en) * 1999-07-13 2001-11-09 Seppic Sa NOVEL METHOD FOR CLEANING AND DISINFECTING A HEMODIALYSIS APPARATUS WITH AN AQUEOUS SOLUTION COMPRISING A SURFACTANT AND AN ACTIVE OXYGEN GENERATOR AND NEW COMPOSITION
FR2796286B1 (en) * 1999-11-09 2002-06-07 Seppic Sa NOVEL COMPOSITION IN THE FORM OF AN AQUEOUS SOLUTION OF PERACETIC ACID AND USE OF SAID COMPOSITION FOR DISINFECTING MEDICAL AND SURGICAL MATERIALS AND DENTISTRY MATERIALS
KR100363896B1 (en) * 2000-04-21 2002-12-16 이진식 A medical instrument cleaning solution using peracetic acid and the manufacturing method of the above solution
US6444435B1 (en) 2000-11-30 2002-09-03 Serim Research Corporation Test strip for determining dialysate composition
JP4375950B2 (en) * 2002-07-16 2009-12-02 日本パーオキサイド株式会社 Disinfectant composition
KR100515929B1 (en) * 2002-08-28 2005-09-20 이진식 A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 2
KR100515928B1 (en) * 2002-08-28 2005-09-20 이진식 A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 1
CA2620811A1 (en) 2005-09-27 2007-04-05 Siemens Water Technologies Corp. Chemical cleaning agent and process for cleaning filtration membranes
FR2898061B1 (en) * 2006-03-03 2012-07-13 Seppic Sa NOVEL CLEANING, DECALCIFYING AND DISINFECTING COMPOSITION FOR DIALYSIS GENERATORS
US9271494B2 (en) * 2007-08-30 2016-03-01 Ecolab USA, Inc. Shelf stable, reduced corrosion, ready to use peroxycarboxylic acid antimicrobial compositions
JP2011502143A (en) * 2007-10-31 2011-01-20 リ、ジン−シク Bactericidal composition comprising peracid and acetylsalicylic acid
EP2378874A2 (en) * 2008-12-18 2011-10-26 Minntech Corporation Sporicidal hand sanitizing lotion
FR3009197B1 (en) * 2013-08-02 2015-07-31 Cair L G L TETRAACETYLETHYLENEDIAMINE COMPOSITION FOR THE GENERATION OF PERACETIC ACID
JP6359865B2 (en) * 2014-04-22 2018-07-18 保土谷化学工業株式会社 Non-corrosive peracetic acid preparation and its production method

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE96833C (en) *
DE2623917A1 (en) * 1976-05-28 1977-12-15 Edel Heinz H Cleaning used haemodialysers simply and effectively - by passing a soln. contg. hydrogen peroxide through
US4209402A (en) * 1977-07-12 1980-06-24 Gentles William M Kidney dialysis filter washing process
DE3134050A1 (en) * 1981-08-28 1983-03-10 Dr. Franz Köhler Chemie GmbH, 6146 Alsbach Solution for sterilising and removing pyrogens from stainless steel lines and filters in a closed system
US4444597A (en) * 1980-03-03 1984-04-24 Norman Gortz Automated cleaning method for dialyzers
US4552721A (en) * 1983-08-19 1985-11-12 Baxter Travenol Laboratories, Inc. Method for disinfecting, for reuse, separation devices for blood and associated fluid lines
US4587264A (en) * 1982-02-24 1986-05-06 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Disinfection and sterilizing solution of peracetic acid and nitric acid
EP0193416A1 (en) * 1985-01-30 1986-09-03 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Sterilizing composition for contact lenses
FR2584503A1 (en) * 1985-02-07 1987-01-09 Laroche Jean Michel Method for sterilising contact lenses
US4680163A (en) * 1984-04-14 1987-07-14 Kolbus Gmbh & Co. Kg Process and apparatus for sterilizing containers
US4690772A (en) * 1985-06-03 1987-09-01 National Medical Care Sterilant compositions
US4695385A (en) * 1985-04-29 1987-09-22 Colorado Medical, Inc. Dialyzer reuse system
WO1988008667A1 (en) * 1987-05-14 1988-11-17 Minntech Corporation Stable, shippable, peroxy-containing microbicide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639233B1 (en) * 1988-11-23 1994-05-06 Air Liquide HEMODIALYSIS HYGIENE AGENT

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE96833C (en) *
DE2623917A1 (en) * 1976-05-28 1977-12-15 Edel Heinz H Cleaning used haemodialysers simply and effectively - by passing a soln. contg. hydrogen peroxide through
US4209402A (en) * 1977-07-12 1980-06-24 Gentles William M Kidney dialysis filter washing process
US4444597A (en) * 1980-03-03 1984-04-24 Norman Gortz Automated cleaning method for dialyzers
DE3134050A1 (en) * 1981-08-28 1983-03-10 Dr. Franz Köhler Chemie GmbH, 6146 Alsbach Solution for sterilising and removing pyrogens from stainless steel lines and filters in a closed system
US4587264A (en) * 1982-02-24 1986-05-06 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Disinfection and sterilizing solution of peracetic acid and nitric acid
US4552721A (en) * 1983-08-19 1985-11-12 Baxter Travenol Laboratories, Inc. Method for disinfecting, for reuse, separation devices for blood and associated fluid lines
US4680163A (en) * 1984-04-14 1987-07-14 Kolbus Gmbh & Co. Kg Process and apparatus for sterilizing containers
EP0193416A1 (en) * 1985-01-30 1986-09-03 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Sterilizing composition for contact lenses
US4743447A (en) * 1985-01-30 1988-05-10 L'air Liquide Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Composition for disinfecting contact lenses
FR2584503A1 (en) * 1985-02-07 1987-01-09 Laroche Jean Michel Method for sterilising contact lenses
US4695385A (en) * 1985-04-29 1987-09-22 Colorado Medical, Inc. Dialyzer reuse system
US4690772A (en) * 1985-06-03 1987-09-01 National Medical Care Sterilant compositions
WO1988008667A1 (en) * 1987-05-14 1988-11-17 Minntech Corporation Stable, shippable, peroxy-containing microbicide

Non-Patent Citations (22)

* Cited by examiner, † Cited by third party
Title
F. Dumler et al; "Effect of Dialyzer Reprocessing Methods on Complement Activation and Hemodialyzer-Related Symptoms"; Artificial Organs; 11(2):128-131, 1987.
F. Dumler et al; Effect of Dialyzer Reprocessing Methods on Complement Activation and Hemodialyzer Related Symptoms ; Artificial Organs; 11(2):128 131, 1987. *
F. P. Greenspan et al; "Peracetic Acid Aerosols"; pp. 59-64 (1955).
F. P. Greenspan et al; Peracetic Acid Aerosols ; pp. 59 64 (1955). *
H. Bauer et al; "Experience with the Disinfectant Peroxyacetic Acid (PES) for Hemodialyzer Reuse"; Trans-Am Soc. Artif. Intern. Organs, vol. 29, pp. 662-665, 1983.
H. Bauer et al; Experience with the Disinfectant Peroxyacetic Acid (PES) for Hemodialyzer Reuse ; Trans Am Soc. Artif. Intern. Organs, vol. 29, pp. 662 665, 1983. *
H. Briedigkeit et al, "Investigations Into The Disinfection of Hemodialysis Equipment", Zschr. Urol. 70, 705-711 (1977).
H. Briedigkeit et al, Investigations Into The Disinfection of Hemodialysis Equipment , Zschr. Urol. 70, 705 711 (1977). *
H. Feldman; "Removing Deposits from Drinking Water Storage Vessels"; Water, vol. 83, p. 303 (1974).
H. Feldman; Removing Deposits from Drinking Water Storage Vessels ; Water, vol. 83, p. 303 (1974). *
H. Wenchel et al, "Microbe Reproduction In Various Sections of A Dialyser By Peracetic Acid Preparations", Hygiene & Medicin 12, 197-202 (1987).
H. Wenchel et al, Microbe Reproduction In Various Sections of A Dialyser By Peracetic Acid Preparations , Hygiene & Medicin 12, 197 202 (1987). *
L. J. Fischbach; "Renalin: Qualification As a Dialyzer Sterilant"; pp. 15-19 (1985).
L. J. Fischbach; Renalin: Qualification As a Dialyzer Sterilant ; pp. 15 19 (1985). *
M. Baldry; "Peroxygen Biocides in the Food and Drink Industry"; Biesterfeld, pp. 1-2; 11-12; 12-13 (1984).
M. Baldry; Peroxygen Biocides in the Food and Drink Industry ; Biesterfeld, pp. 1 2; 11 12; 12 13 (1984). *
M. Sproeig et al, "Disinfection of Hemodialysis Systems with Peracetic Acid", Dtsch. Ges. Wesen 27, 1085-1089 (1972).
M. Sproeig et al, Disinfection of Hemodialysis Systems with Peracetic Acid , Dtsch. Ges. Wesen 27, 1085 1089 (1972). *
R. Giertler, et al "Further Investigations On The Disinfection of Artificial Kidneys With Peracetic Acid", Zschr. Urol. 66, 689-694 (1973).
R. Giertler, et al Further Investigations On The Disinfection of Artificial Kidneys With Peracetic Acid , Zschr. Urol. 66, 689 694 (1973). *
Seymour S. Block, Disinfection, Sterilization, and Preservation , Third Ed., (1983), pp. 401 402. *
Seymour S. Block, Disinfection, Sterilization, and Preservation, Third Ed., (1983), pp. 401-402.

Cited By (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162394A (en) * 1988-11-23 2000-12-19 L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude Hygienic agent for use in hemodialysis
US6168808B1 (en) * 1997-04-24 2001-01-02 Chemoxal Sa Synergistic composition of peracetic acid and amine oxide
US6444230B1 (en) * 1997-04-24 2002-09-03 Chemoxal Sa Synergistic composition of peracetic acid and amine oxide
US6545047B2 (en) 1998-08-20 2003-04-08 Ecolab Inc. Treatment of animal carcasses
US8030351B2 (en) 1998-08-20 2011-10-04 Ecolab, Inc. Treatment of animal carcasses
US8043650B2 (en) 1998-08-20 2011-10-25 Ecolab Inc. Treatment of animal carcasses
US9560875B2 (en) 1998-08-20 2017-02-07 Ecolab Usa Inc. Treatment of animal carcasses
US9560874B2 (en) 1998-08-20 2017-02-07 Ecolab Usa Inc. Treatment of animal carcasses
US9770040B2 (en) 1998-08-20 2017-09-26 Ecolab Usa Inc. Treatment of animal carcasses
US20040060865A1 (en) * 1998-10-20 2004-04-01 Robin Callan Buffered compositions for dialysis
US9216247B2 (en) 1998-10-20 2015-12-22 Advanced Renal Technologies Buffered compositions for dialysis
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
US20100170849A1 (en) * 1998-10-20 2010-07-08 Advanced Renal Technologies Buffered compositions for dialysis
US20100176340A1 (en) * 1998-10-20 2010-07-15 Advanced Renal Technologies Buffered compositions for dialysis
US6468472B1 (en) 1999-09-16 2002-10-22 Metrex Research Corporation Cleaning and decontaminating dialyzers by per-compound solutions
WO2001019414A1 (en) * 1999-09-16 2001-03-22 Metrex Research Corporation Cleaning and decontaminating dialyzers by per-compound solutions
US7862530B2 (en) 1999-09-22 2011-01-04 Advanced Renal Technologies High citrate dialysate and uses thereof
US20050119598A1 (en) * 1999-09-22 2005-06-02 Advanced Renal Technologies High citrate dialysate and uses thereof
US8864699B2 (en) 1999-09-22 2014-10-21 Advanced Renal Technologies High citrate dialysate and uses thereof
US20110172583A1 (en) * 1999-09-22 2011-07-14 Advanced Renal Technologies High citrate dialysate and uses thereof
WO2001036076A1 (en) * 1999-11-12 2001-05-25 Minntech Corporation Method and product for cleaning hollow fiber material and filter
EP1230000A4 (en) * 1999-11-12 2003-01-22 Minntech Corp Method and product for cleaning hollow fiber material and filter
US6261457B1 (en) * 1999-11-12 2001-07-17 Minntech Corporation Method and product for cleaning hollow fiber material and filter
US6927237B2 (en) 2000-04-28 2005-08-09 Ecolab Inc. Two solvent antimicrobial compositions and methods employing them
US8246906B2 (en) 2000-04-28 2012-08-21 Ecolab Usa Inc. Antimicrobial composition
US9247738B2 (en) 2000-07-12 2016-02-02 Ecolab Usa Inc. Method and composition for inhibition of microbial growth in aqueous food transport and process streams
US8124132B2 (en) 2000-07-12 2012-02-28 Ecolab Usa Inc. Method and composition for inhibition of microbial growth in aqueous food transport and process streams
US10342231B2 (en) 2000-07-12 2019-07-09 Ecolab Usa Inc. Method and composition for inhibition of microbial growth in aqueous food transport and process streams
US7150884B1 (en) 2000-07-12 2006-12-19 Ecolab Inc. Composition for inhibition of microbial growth
US6479454B1 (en) 2000-10-05 2002-11-12 Ecolab Inc. Antimicrobial compositions and methods containing hydrogen peroxide and octyl amine oxide
US8020520B2 (en) 2000-12-15 2011-09-20 Ecolab Usa Inc. Method and composition for washing poultry during processing
US7381439B2 (en) 2000-12-15 2008-06-03 Ecolab Inc. Method and composition for washing poultry during processing
US7316824B2 (en) 2000-12-15 2008-01-08 Ecolab Inc. Method and composition for washing poultry during processing
US7832360B2 (en) 2000-12-15 2010-11-16 Ecolab Usa Inc. Method and composition for washing poultry during processing
US6964787B2 (en) 2001-02-01 2005-11-15 Ecolab Inc. Method and system for reducing microbial burden on a food product
US7060301B2 (en) 2001-07-13 2006-06-13 Ecolab Inc. In situ mono-or diester dicarboxylate compositions
US6627593B2 (en) 2001-07-13 2003-09-30 Ecolab Inc. High concentration monoester peroxy dicarboxylic acid compositions, use solutions, and methods employing them
US7816555B2 (en) 2003-01-17 2010-10-19 Ecolab Inc. Peroxycarboxylic acid compositions with reduced odor
US7622606B2 (en) 2003-01-17 2009-11-24 Ecolab Inc. Peroxycarboxylic acid compositions with reduced odor
US8388944B2 (en) 2003-06-23 2013-03-05 Novasterilis Inc. Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
US7108832B2 (en) * 2003-06-23 2006-09-19 Novasterilis Inc. Sterialization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
US8974730B2 (en) 2003-06-23 2015-03-10 Novasterilis, Inc. Process for creating acellular viable donor soft tissue
US20110014184A1 (en) * 2003-06-23 2011-01-20 Christensen Tim W Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
US20090246193A1 (en) * 2003-06-23 2009-10-01 Christensen Tim W Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
US7919096B2 (en) 2003-06-23 2011-04-05 Novasterilis, Inc. Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
US20050025667A1 (en) * 2003-06-23 2005-02-03 Novasterilis Inc. Sterilization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
US8034288B2 (en) 2003-06-23 2011-10-11 Novasterilis Method and apparatus for cleaning of viable donor soft tissue
US20080166266A1 (en) * 2003-06-23 2008-07-10 Burns David C Method and Apparatus for Cleaning of Viable Donor Soft Tissue
US7504123B2 (en) 2004-01-09 2009-03-17 Ecolab Inc. Methods for washing poultry during processing with medium chain peroxycarboxylic acid compositions
US9888684B2 (en) 2004-01-09 2018-02-13 Ecolab Usa Inc. Medium chain perosycarboxylic acid compositions
US10568322B2 (en) 2004-01-09 2020-02-25 Ecolab Usa Inc. Medium chain peroxycarboxylic acid compositions
US7569232B2 (en) 2004-01-09 2009-08-04 Ecolab Inc. Medium chain peroxycarboxylic acid compositions
US8057812B2 (en) 2004-01-09 2011-11-15 Ecolab Usa Inc. Medium chain peroxycarboxylic acid compositions
US9491965B2 (en) 2004-01-09 2016-11-15 Ecolab Usa Inc. Medium chain peroxycarboxylic acid compositions
US7887641B2 (en) 2004-01-09 2011-02-15 Ecolab Usa Inc. Neutral or alkaline medium chain peroxycarboxylic acid compositions and methods employing them
US8128976B2 (en) 2004-01-09 2012-03-06 Ecolab Usa Inc. Methods for washing poultry during processing with medium chain peroxycarboxylic acid compositions
US8187652B2 (en) 2004-01-09 2012-05-29 Ecolab Usa Inc. Methods for washing carcasses, meat, or meat products with medium chain peroxycarboxlyic acid compositions
US7771737B2 (en) 2004-01-09 2010-08-10 Ecolab Inc. Medium chain peroxycarboxylic acid compositions
US8318188B2 (en) 2004-01-09 2012-11-27 Ecolab Usa Inc. Medium chain peroxycarboxylic acid compositions
US9511161B2 (en) 2004-01-09 2016-12-06 Ecolab Usa Inc. Methods for reducing the population of arthropods with medium chain peroxycarboxylic acid compositions
US8758789B2 (en) 2004-01-09 2014-06-24 Ecolab Usa Inc. Medium chain peroxycarboxylic acid compositions
US7507429B2 (en) 2004-01-09 2009-03-24 Ecolab Inc. Methods for washing carcasses, meat, or meat products with medium chain peroxycarboxylic acid compositions
US20100087530A1 (en) * 2004-01-09 2010-04-08 Ecolab Inc. Methods for washing poultry during processing with medium chain peroxycarboxylic acid compositions
US7504124B2 (en) 2004-01-09 2009-03-17 Ecolab Inc. Methods for washing carcasses, meat, or meat product with medium chain peroxycarboxylic acid compositions
US7498051B2 (en) 2004-01-09 2009-03-03 Ecolab Inc. Methods for washing poultry during processing with medium chain peroxycarboxylic acid compositions
US8999175B2 (en) 2004-01-09 2015-04-07 Ecolab Usa Inc. Methods for washing and processing fruits, vegetables, and other produce with medium chain peroxycarboxylic acid compositions
WO2005092397A1 (en) * 2004-03-01 2005-10-06 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Dialyzing plant
US9167814B2 (en) 2005-07-06 2015-10-27 Ecolab USA, Inc. Surfactant peroxycarboxylic acid compositions
US7754670B2 (en) 2005-07-06 2010-07-13 Ecolab Inc. Surfactant peroxycarboxylic acid compositions
US8957246B2 (en) 2006-10-18 2015-02-17 Ecolab USA, Inc. Method for making a peroxycarboxylic acid
US9708256B2 (en) 2006-10-18 2017-07-18 Ecolab Usa Inc. Method for making a peroxycarboxylic acid
US8017082B2 (en) 2006-10-18 2011-09-13 Ecolab Usa Inc. Apparatus and method for making a peroxycarboxylic acid
US7547421B2 (en) 2006-10-18 2009-06-16 Ecolab Inc. Apparatus and method for making a peroxycarboxylic acid
US8075857B2 (en) 2006-10-18 2011-12-13 Ecolab Usa Inc. Apparatus and method for making a peroxycarboxylic acid
US9288982B2 (en) 2006-10-18 2016-03-22 Ecolab USA, Inc. Method for making a peroxycarboxylic acid
US20100076082A1 (en) * 2007-04-12 2010-03-25 Bioxal New Cleaning, Descaling and Disinfecting Composition for Dialysis Generators
US8889081B2 (en) 2009-10-15 2014-11-18 Medivators Inc. Room fogging disinfection system
US9511162B2 (en) 2009-10-15 2016-12-06 Mar Cor Purification, Inc. Room fogging disinfection system and method
US20110091354A1 (en) * 2009-10-15 2011-04-21 Minntech Corporation Room fogging disinfection system
US20110135537A1 (en) * 2009-12-03 2011-06-09 Minntech Corporation Container and system for decontaminating a medical device with a fog
US9439991B2 (en) 2009-12-03 2016-09-13 Medivators Inc. Container and system for decontaminating a medical device with a fluid
US8821807B2 (en) 2009-12-03 2014-09-02 Medivators Inc. Container and system for decontaminating a medical device with a fog
US9017607B2 (en) 2011-05-27 2015-04-28 Medivators Inc. Decontamination system including environmental control using a decontaminating substance
US9402929B2 (en) 2011-05-27 2016-08-02 Mar Cor Purification, Inc. Decontamination system including environmental control using a decontaminating substance
US9752105B2 (en) 2012-09-13 2017-09-05 Ecolab Usa Inc. Two step method of cleaning, sanitizing, and rinsing a surface
US10358622B2 (en) 2012-09-13 2019-07-23 Ecolab Usa Inc. Two step method of cleaning, sanitizing, and rinsing a surface
US12337073B2 (en) 2013-04-15 2025-06-24 Ecolab Usa Inc. Peroxycarboxylic acid based sanitizing rinse additives for use in ware washing
US11865219B2 (en) 2013-04-15 2024-01-09 Ecolab Usa Inc. Peroxycarboxylic acid based sanitizing rinse additives for use in ware washing
US20150305342A1 (en) * 2014-04-28 2015-10-29 American Sterilizer Company Process and composition for killing spores
US20150373986A1 (en) * 2014-04-28 2015-12-31 American Sterilizer Company Process and composition for killing spores
WO2015167642A1 (en) * 2014-04-28 2015-11-05 American Sterilizer Company Composition containing peroxide and an antimicrobial agent and process of killing spores
WO2015167641A1 (en) * 2014-04-28 2015-11-05 American Sterilizer Company Composition containing peroxide and peracetic acid and process of killing spores
US20150305343A1 (en) * 2014-04-28 2015-10-29 American Sterilizer Company Process and composition for killing spores
US10455838B2 (en) * 2014-04-28 2019-10-29 American Sterilizer Company Wipe for killing spores
US10463754B2 (en) * 2014-04-28 2019-11-05 American Sterilizer Company Process for decontaminating or sterilizing an article
US20160021888A1 (en) * 2014-04-28 2016-01-28 American Sterilizer Company Wipe for killing spores
EP3136861B1 (en) 2014-04-28 2020-03-25 American Sterilizer Company Composition containing peroxide and an antimicrobial agent and process of killing spores
US10750749B2 (en) * 2014-04-28 2020-08-25 American Sterilizer Company Process and composition for killing spores
US10869479B2 (en) * 2014-04-28 2020-12-22 American Sterilizer Company Wipe for killing spores
US20170000117A1 (en) * 2014-04-28 2017-01-05 American Sterilizer Company Wipe for killing spores
US20150306266A1 (en) * 2014-04-28 2015-10-29 American Sterilizer Company Process for decontaminating or sterilizing an article
US11241658B2 (en) 2018-02-14 2022-02-08 Ecolab Usa Inc. Compositions and methods for the reduction of biofilm and spores from membranes

Also Published As

Publication number Publication date
JPH02193905A (en) 1990-07-31
FR2639233B1 (en) 1994-05-06
FR2639233A1 (en) 1990-05-25
ATE92254T1 (en) 1993-08-15
EP0370850B1 (en) 1993-08-04
JP2599204B2 (en) 1997-04-09
US6162394A (en) 2000-12-19
DE68908101D1 (en) 1993-09-09
CA2003476C (en) 2000-04-04
DE68908101T2 (en) 1994-01-13
CA2003476A1 (en) 1990-05-23
ES2043067T3 (en) 1993-12-16
EP0370850A1 (en) 1990-05-30

Similar Documents

Publication Publication Date Title
US5851483A (en) Hygienic agent for use in hemodialysis
US5698100A (en) Bacteriostatic dialyzers containing citric acid solutions
JP2535147B2 (en) Disinfectant composition
US4148606A (en) Sterilization of dialyzer
US5628959A (en) Composition and methods for sterilizing dialyzers
US5192459A (en) Sterilant compositions
US5360605A (en) Preservation of blood, tissues and biological fluids
US5019402A (en) Composition and procedure for disinfecting blood and blood components
US20100076082A1 (en) New Cleaning, Descaling and Disinfecting Composition for Dialysis Generators
US5591350A (en) Iodine disinfection method using a gaseous iodine treated porous medium
Vanatta et al. Improvements on the artificial kidney: an experimental study of its application to dogs bilaterally nephrectomized or otherwise deprived of renal function
TW415847B (en) Decontamination method and composition therefor
WO1994000161A1 (en) Povidone hydrogen peroxide preservation of blood, tissues and biological fluids
WO1994000011A1 (en) Starch-iodine-peroxide preservation of blood, tissues and biological fluids
WO1994006289A1 (en) A method of inactivating microbes in blood using iodine
Bok et al. Can we do without dialyzer reuse?
Nystrand On‐line technique for producing substitution fluid in haemodiafiltration and haemofiltration
JPS5934379B2 (en) Method for manufacturing heat sterilized artificial kidney

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20101222